Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis of Influenza”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00537524
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Who this might be right for
Prophylaxis of Avian Influenza
Novartis Vaccines 471
Large-scale testing (Phase 3)Study completedNCT01961960
What this trial is testing

Evaluate Intramuscular ASP7374

Who this might be right for
InfluenzaVaccine
UMN Pharma Inc. 55
Not applicableLooking for participantsNCT07314593
What this trial is testing

Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults.

Who this might be right for
Respiratory Infections
Landspitali University Hospital 400
Early research (Phase 1)Study completedNCT00646152
What this trial is testing

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

Who this might be right for
InfluenzaSevere Acute Respiratory Distress SyndromeSmallpox+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 57
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Large-scale testing (Phase 3)Active Not RecruitingNCT07159763
What this trial is testing

Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

Who this might be right for
Influenza
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 10,000
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Large-scale testing (Phase 3)Study completedNCT00316147
What this trial is testing

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

Who this might be right for
DiphtheriaAcellular PertussisTetanus+3 more
GlaxoSmithKline 224
Post-approval studies (Phase 4)Study completedNCT03370289
What this trial is testing

Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects

Who this might be right for
Pandemic Influenza Prevention
Takeda 55
Testing effectiveness (Phase 2)Study completedNCT06609460
What this trial is testing

Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications

Who this might be right for
Influenza
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 5,071
Not applicableStudy completedNCT01248520
What this trial is testing

Influenza and Text Messaging in Pregnancy

Who this might be right for
Pregnancy
University of Pittsburgh 216
Testing effectiveness (Phase 2)Study completedNCT00504231
What this trial is testing

Intradermal Influenza Vaccine Study in Elders

Who this might be right for
Influenza
PATH 257
Post-approval studies (Phase 4)Study completedNCT00412555
What this trial is testing

Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Who this might be right for
Influenza
Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT00363077
What this trial is testing

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

Who this might be right for
Influenza
GlaxoSmithKline 150
Early research (Phase 1)Study completedNCT01302990
What this trial is testing

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

Who this might be right for
Flu
Medicago 100
Early research (Phase 1)Study completedNCT03121339
What this trial is testing

Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults

Who this might be right for
Seasonal Influenza Preventative Vaccine Pharmacodynamics
Vaxart 8
Testing effectiveness (Phase 2)Study completedNCT00306995
What this trial is testing

Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 385